Ra Capital Management, L.P.

13F Holdings History for LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Symbol: LENZ on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 4.27M shares
Security Ownership: 13.6%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

2025-11-07 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.27M shares of LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ). This represents 13.6% percent ownership of the company. In their previous filing dated 2025-05-09, RA CAPITAL MANAGEMENT, L.P. had reported owning 4.26M shares, indicating an increase of 0.11% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
RA Capital Management, L.P.	13.6%	-10%	$199M	4.27M	+4,500	+0.11%	$46.58	13D/A	11/5/2025	7 Nov 2025 16:47:28
RA Capital Management, L.P.	15.1%		$79M	4.26M			$18.54	13D/A	5/7/2025	9 May 2025 16:19:30

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	2.4%		$195M	4.18M			$46.58	Q3 2025
6/30/2025	2.06%		$122M	4.18M			$29.31	Q2 2025
3/31/2025	1.79%		$107M	4.18M			$25.71	Q1 2025
12/31/2024	1.61%		$121M	4.18M			$28.87	Q4 2024
9/30/2024	1.14%		$99.2M	4.18M			$23.74	Q3 2024
6/30/2024	0.96%		$72.3M	4.18M			$17.29	Q2 2024
3/31/2024	1.21%	+1.46%	$93.3M	4.18M	+4,178,823	NEW	$22.33	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.